Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Coagulation Disorders » Blood Coagulation Disorders, Inherited
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Blood Coagulation Disorders, Inherited
Description
Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation. MeSH
Hierarchy View
Subtype Terms (19)
Activated Protein C Resistance
2 approved drugs
Afibrinogenemia
2 approved drugs
Antithrombin III Deficiency
3 drugs (2 approved, 1 experimental)
Factor VII Deficiency
7 drugs (3 approved, 4 experimental)
Factor X Deficiency
1 approved drug
Factor XI Deficiency
1 approved drug
Factor XIII Deficiency
1 approved drug
Hemophilia A
99 drugs (49 approved, 50 experimental)
Hemophilia B
49 drugs (18 approved, 31 experimental)
Hermanski-Pudlak Syndrome
12 approved drugs
Hypoprothrombinemias
3 approved drugs
Protein C Deficiency
1 approved drug
Thrombasthenia
10 drugs (8 approved, 2 experimental)
von Willebrand Diseases
16 drugs (8 approved, 8 experimental)
Wiskott-Aldrich Syndrome
34 drugs (25 approved, 9 experimental)
Organization Involved with Phase 2 Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
